Patents by Inventor Paul Perco

Paul Perco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENISTEIN FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
    Publication number: 20240058298
    Abstract: The present invention relates to a pharmaceutical preparation comprising genistein, or a salt or solvate thereof, for use in the treatment of focal segmental glomerulosclerosis (FSGS).
    Type: Application
    Filed: December 3, 2021
    Publication date: February 22, 2024
    Inventor: Paul Perco
  • SAROGLITAZAR AND MYRISTIC ACID FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
    Publication number: 20240041825
    Abstract: The present invention relates to a pharmaceutical preparation comprising saroglitazar and myristic acid, or a salt or solvate thereof, for use in the treatment of focal segmental glomerulosclerosis (FSGS).
    Type: Application
    Filed: December 3, 2021
    Publication date: February 8, 2024
    Inventor: Paul Perco
  • CLOPIDOGREL FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
    Publication number: 20240016785
    Abstract: The present invention relates to a pharmaceutical preparation comprising clopidogrel, or a salt or solvate thereof, for use in the treatment of focal segmental glomerulosclerosis (FSGS).
    Type: Application
    Filed: December 3, 2021
    Publication date: January 18, 2024
    Inventor: Paul Perco
  • ANTIVIRAL USE OF LIRAGLUTIDE AND GEFITINIB
    Publication number: 20230270826
    Abstract: The present invention refers to a pharmaceutical preparation comprising liraglutide or gefitinib or a salt, solvate or combination thereof, in an effective amount for use in prophylactic or therapeutic treatment of a disease condition which is caused by or associated with an infection by a coronavirus.
    Type: Application
    Filed: July 30, 2021
    Publication date: August 31, 2023
    Inventor: Paul PERCO
  • Acute kidney injury risk testing
    Patent number: 8728984
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of one or more marker(s) selected from REN, SLC38A4, IL17RB, TMEM149, FLRT3, and CATSPERG or any combination thereof in a sample.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: May 20, 2014
    Inventors: Rainer Oberbauer, Julia Wilflingseder, Bernd Mayer, Paul Perco, Alexander Kainz
  • MARKERS OF ACUTE KIDNEY FAILURE
    Publication number: 20130172205
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
    Type: Application
    Filed: December 4, 2012
    Publication date: July 4, 2013
    Inventors: Rainer Oberbauer, Bernd Mayer, Paul Perco, Alexander Kainz
  • Markers of acute kidney failure
    Patent number: 8338096
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
    Type: Grant
    Filed: April 15, 2009
    Date of Patent: December 25, 2012
    Inventors: Rainer Oberbauer, Alexander Kainz, Bernd Mayer, Paul Perco
  • ACUTE KIDNEY INJURY RISK TESTING
    Publication number: 20120202705
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of one or more marker(s) selected from REN, SLC38A4, IL17RB, TMEM149, FLRT3, and CATSPERG or any combination thereof in a sample.
    Type: Application
    Filed: October 8, 2010
    Publication date: August 9, 2012
    Inventors: Rainer Oberbauer, Julia Wilflingseder, Bernd Mayer, Paul Perco, Alexander Kainz
  • METHOD OF DIAGNOSING RENAL DISORDERS
    Publication number: 20120088689
    Abstract: The invention refers to an in vitro method of determining the risk of renal disorders, in a patient, by measuring a VCAN parameter, characterized in that at least one of the isoforms V0 and V1 are specifically determined in a sample of said patient and compared to a reference level.
    Type: Application
    Filed: June 7, 2011
    Publication date: April 12, 2012
    Inventors: Gert Mayer, Michael Rudnicki, Paul Perco
  • MARKERS OF ACUTE KIDNEY FAILURE
    Publication number: 20110059857
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
    Type: Application
    Filed: April 15, 2009
    Publication date: March 10, 2011
    Inventors: Rainer Oberbauer, Bernd Mayer, Paul Perco, Alexander Kainz
  • METHOD OF DIAGNOSING A PROGRESSIVE DISEASE
    Publication number: 20110009285
    Abstract: A method of determining the risk of progressive renal disease in a patient, by measuring a parameter related to a marker selected from the group of IL1RN, ISG15, LIFR, C6, IL32 and any combination thereof, in a sample of said patient.
    Type: Application
    Filed: December 19, 2008
    Publication date: January 13, 2011
    Inventors: Gert Mayer, Michael Rudnicki, Susanne Eder, Gabriele Schratzberger, Julia Enrich, Paul Perco